|
HS Code |
172078 |
| Chemical Name | (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol |
| Cas Number | 112022-70-9 |
| Molecular Formula | C23H28O8S2 |
| Molecular Weight | 496.59 |
| Appearance | White to off-white solid |
| Melting Point | 139-140°C |
| Solubility | Soluble in common organic solvents such as dichloromethane and chloroform |
| Optical Rotation | [α]20D -10° to -14° (c=1, CHCl3) |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C, protected from light and moisture |
| Synonyms | (-)-DITHP, (-)-Di-O-Tosyl Isopropylidenethreitol |
| Usage | Chiral building block and reagent in organic synthesis |
As an accredited (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 25g amber glass bottle with a screw cap, labeled with product details and safety information. |
| Shipping | This chemical, `(-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol`, is shipped in secure, sealed containers to prevent contamination and degradation. It is packed with appropriate labeling and documentation, handled in accordance with relevant chemical safety regulations, and transported via reliable couriers to ensure safe and timely delivery to the specified destination. |
| Storage | (-)-1,4-Di-O-Tosyl-2,3-O-isopropylidenethreitol should be stored in a tightly sealed container, protected from moisture and light, at a cool temperature (2–8°C, refrigerator). Store in a well-ventilated, dry area away from incompatible substances such as strong oxidizing agents and acids. Avoid prolonged exposure to air. Always follow local safety regulations when handling and storing chemical substances. |
Applications of (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol in Industrial ManufacturingAs an original manufacturer, we supply (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol with strict quality control for advanced sectors. The following application scenarios represent verified, compliant uses addressing today's demands in pharmaceutical synthesis, fine chemical production, and specialty intermediates manufacturing. 1. Chiral Auxiliary in Asymmetric Synthesis for Active Pharmaceutical Ingredients (APIs)Professional pharmaceutical processors use this raw material as a chiral auxiliary to induce high enantioselectivity in the synthesis of drug molecules with complex stereochemistry. It plays a direct role in multi-step processes for antidiabetic, antiviral, and cardiovascular APIs where absolute stereocontrol is crucial during carbon–carbon bond formation and ring-closing reactions. Plant QC departments monitor trace impurities and recover auxiliaries post-reaction, complying with strict global regulations for pharmaceutical intermediates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Enantioselective Diol Protection in Complex Natural Product SynthesisResearch and production sites engaged in natural product synthesis use this tosyl-protected acetonide as a protective group control reagent for diols and polyols, permitting selective stepwise deprotection and fine-tuning of reactivity across multifunctional molecules. It allows plant chemists to access intermediates with precisely tailored functional group arrays as demanded by total synthesis protocols for semi-synthetic fine chemicals and fermentation product modification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Stereoselective Building Block in Chiral Ligand and Catalyst ManufacturingCatalyst and ligand producers rely on this intermediate for assembling high-performance chiral ligands applied in asymmetric catalysis for fine chemicals, APIs, and agrochemicals manufacturing. Integration occurs at the ligand scaffold construction stage, providing stereodefined frameworks for transition metal catalysis, especially in cross-coupling and hydrogenation applications. Batch records track configuration and purities to ensure reproducible performance in downstream catalytic steps. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Key Intermediate for Stereoselective Synthesis of Advanced Glycosidase InhibitorsProducers of glycosidase inhibitors for the pharmaceutical and biotechnology markets utilize this acetonide-protected, bis-tosylated material for the synthesis of highly functionalized intermediates. In these applications, plant chemists perform nucleophilic substitutions and cyclizations with enantiopure control, ensuring the correct stereochemistry required for substrate mimicry in enzyme inhibitory therapies, including rare disease and metabolic syndrome treatments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Formulating advanced intermediates demands more than theoretical know-how and purified analytes. From years of synthesis experience in our plant, consistent success in multi-step chemistry rests on the right choice of chiral building blocks. (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol represents one of those rare cases where utility meets reliability—a product born from repeated trial, lab adaptation, and a persistent push for higher yields across enantioselective transformations.
Drawn from the structures of C2-symmetric four-carbon sugars, this compound brings clarity and order to asymmetric synthesis. Its structure allows clean introduction of diol motifs while affording exceptional leaving group behavior at the tosyl positions. Time and again, process chemists rely on it to get cleaner separations, faster reactions, and better control over stereochemistry during coupling or further modification steps.
We do not substitute rigorous filtration and monitored distillation when crafting (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol. Batch control means monitoring pressure, temperature, and feed ratios in real time—parameters still easily botched by shortcut chemistry or imprecise instrumentation. On our floor, every step from crude diol formation through tosylation gets tracked for chiral purity by HPLC and documented for spectral identity.
Ongoing feedback from research partners and production chemists feeds improvements. Decades of hands-on formulation have shown that trace water or residual acid throws off crystallization, so our protocols spot-check for water content below 0.1% and push every lot to exceed 98% chiral purity—sampled as both neat solid and in solution. It costs more in raw labor but cuts headaches from failed scale-up or batch rework. Testing doesn't stop at the drum; random packaging inspection ensures protection in storage and transit, avoiding the risk of clumps or hydrolysis after shipment.
Consistently, our in-house preparation delivers (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol as a crystalline solid with particle sizing controlled to minimize dust, allowing easy handling for glovebox work or bulk scale. Melting point routinely sits in the expected range for this diol-diether, and repeated analyses have confirmed the assigned stereochemistry. No parochial or vendor-provided library; we back each lot with NMR, MS, and polarimetry data from our own chemists and raw material tracking that follows every drum from warehouse to reactor.
The product releases in bulk or research grades. Most frequent requests come for kilogram and multi-kilogram orders. We support smaller scales for early synthesis or analytical method development. Our experience shows maintaining the same grade for both R&D and production stops process drift and avoids headaches scaling reactions from gram to multi-kilogram levels.
Any diol can carry tosyl groups, but years synthesizing C2-symmetric intermediates exposed key differences. The (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol structure locks carbons 2 and 3 with an isopropylidene acetal. This sacrifices flexibility, but gains predictable reactivity. In practice, that acetal means lower reactivity towards unwanted side hydrolysis, so batch reproducibility stands up through humid summers and inconsistent warehouse climates.
Other tosylated four-carbon diols, particularly those lacking the acetonide, show frequent migration of tosyl or even elimination under mild conditions. Customers often report scrambled products in recycling batch reactors or loss of yield after cycling crude mother liquors. With our specific acetal-protected format, these headaches do not arise—yield loss from migration or scrambling turns negligible, and the labor of requalification disappears.
For enantioselective applications, the (-)-enantiomer stabilizes downstream intermediates, supporting catalyst design where small differences in building block purity appear big in final product resolution. Many users in pharmaceutical R&D highlight easier chiral pool synthesis using this backbone, especially for relatively unstable heterocyclic or macrocyclic cores. Synthetic flexibility drops if the isopropylidene is not present since direct manipulation of unprotected diols proves less selective and much less efficient in late-stage functionalization.
Products like (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol become essential in peptide scaffold assembly and synthesis of natural product-like molecules. Our colleagues in the field point to several convergent synthesis routes where the stereocontrol at both diol carbons lets them streamline construction of macrocycles, nucleoside analogs, and spirocyclic intermediates—reducing protection/deprotection cycles, and keeping solvent use down.
Process engineers with tight regulatory timelines turn to this product to accelerate routes that might otherwise bog down at purification or diastereomer separation steps. Documented cases show better recovery of final products just by switching starting materials from less robust chiral diols or byproducts-laden reagents to our consistently manufactured tosyl derivative. Bench chemists save time on TLC and HPLC cleanup because predictable reaction progress makes scale-up safer and solveable. Our plant technical support spends less time troubleshooting failed couplings and more on improving throughput for downstream products.
It doesn’t take long in a process plant to appreciate how improper storage degrades sensitive intermediates. With experience, we moved from open bins to moisture-proof sealed packaging using double-laminated bags and tightly sealed containers. The acetal on (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol holds strong during transport, but we still run routine checks on incoming and outgoing lots for water uptake.
Days working in synthesis lines taught us the cost of losing material to caking, off-odors, or color change. Long before this became expected by external audits, we established a quality chain ensuring batches remain bright, crystalline, and free-flowing from filling to delivery. Shipping rarely poses issues with this product, but we guide every user on best storage including chilling where large-scale lots see heat during transfer.
Most chemical plants fear product recalls due to reactivity changes over storage; years supplying this tosylate have demonstrated that acetal stabilization makes a practical difference under real-world conditions. Our records show complaint and requalification rates far lower than with other diol derivatives, easing burden for QA labs downstream.
One recurring lesson from collaborating with synthetic chemists across pharma and materials labs: their most advanced molecules often fail for reasons traceable to one intermediate. Many find (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol delivers an edge where cost of late-stage process failures risks deadlines or IP loss. Its use grew as process development projects attempted higher yields, lower impurity profiles, and stricter stereochemical control.
Specialty catalysis also benefits. Chemists investigating new ligand scaffolds for metal complexes rely on rigid, well-defined chiral building blocks. The structure here brings desirable rigidity—giving sharper NMR signals in complex mixtures, which benefits fast screening and troubleshooting. Transition metal-catalyzed cross-couplings, in particular, exhibit better selectivity with this intermediate due to consistent geometry and less ligand scrambling.
Our internal R&D chemists track how altering the diol acetal structure or substituting alkylidene groups impacts downstream product purity. Through iterative synthesis and direct feedback from in-plant runs, we keep refining protocols to increase output and lower impurity carryover to successive steps. Customers have reported up to 20% improved yields just by switching from less stable analogs.
Years in large-scale synthesis reveal the environmental impacts of unoptimized batch processes. The advantage with this derivative over more sensitive or volatile analogs ties back to predictable reactivity. Waste generation drops because hydrolytic loss diminishes with the acetal in place—so less acid or base is required downstream for neutralization steps. The overall carbon footprint also improves because reaction temperatures remain moderate, limiting the need for energy-intensive cooling or heating.
From the safety side, the relatively stable solid form means fewer concerns about accidental spills or vapor emissions compared to lower-mass, oil-soluble intermediates. In our facility, operators report easier weighing and transfer, and compliance audits consistently mark lower incident rates for this product than for more fragile reagents.
Waste management plans target minimal process solvent residuals, and in years of plant operation, recovery rates from mother liquors average above 95%. Proper handling and experienced plant management minimize employee risk and environmental exposure, supporting both process efficiency and responsible stewardship.
Within our manufacturing chain, traceability goes deeper than a simple batch log. Each shipment draws from master production records documenting instrument calibrations, raw material checks, and in-process controls—vital for meeting the demands of regulated industries. Our systems document each change of raw material supplier and packaging shift, so downstream partners avoid surprises during validation.
Certifications supporting chiral purity, spectral match, and identity remain on file for every lot. Years working under regulatory frameworks drove us to develop archiving and sampling regimens exceeding industry minimums. Recalls or field re-testing remain rare; customers trust our site-specific controls and transparency, which reduces uncertainty during audits and technical transfer.
Feedback cycles involve direct conversations with plant managers or process scientists so changes in specification actually reflect on-the-ground needs. This approach lets us continuously align our output with what real-world chemistry projects require for both internal and external partners.
No single intermediate solves all production problems; experienced hands know that process optimization never stops. Yet, market feedback and our own troubleshooting point to (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol as a backbone of efficient synthesis—particularly where high-value pharmaceutical or specialty chemical targets require robust, predictable, and selective groundwork.
We encourage technical feedback directly from users, embracing both criticism and suggestions for improvement. Often, modifications to grain size, packaging, or handling instructions arise from practical user problems, not just theoretical optimization. For example, we have adjusted crystallization solvents and drum closures based on field advice and supply changes in raw materials, a practice grown out of long-term collaboration rather than short-term salesmanship.
By integrating continuous improvement, scientific validation, and close support for users, our experience with (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol highlights how well-made specialty intermediates move from lab curiosity to backbone of industrial synthesis.
Manufacturing isn’t just about making a chemical; it’s about anticipating challenges for production, scale-up, and innovation. Real-world chemistry has taught us that consistency in critical intermediates pays for itself: lower rates of rework, higher product quality, and smoother audits. Whether supporting contract manufacturing partners, global R&D teams, or internal process scale-up, the proof lies in reliable performance.
We don’t claim to know every challenge a customer might face, but years supplying advanced chiral intermediates like (-)-1,4-Di-O-Tosyl-2,3-O-Isopropylidenethreitol sharpen our focus on process safety, product stability, and technical transparency. These priorities, forged in practice and not just protocol, drive us to keep refining our offering and learning from the community we serve.